The impact of risk status, preexisting morbidity, and polypharmacy on treatment decisions concerning menopausal symptoms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of risk status, preexisting morbidity, and polypharmacy on treatment decisions concerning menopausal symptoms

Published:2005-12 Issue:12 Volume:118 Page:155-162
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Col Nananda F.

Publisher

Elsevier BV

Subject

General Medicine

Reference47 articles.

1. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women;Hulley;JAMA,1998

2. Risks and benefits of estrogen plus progestin in healthy postmenopausal women;Rossouw;JAMA,2002

3. Time to review all the evidence for hormone replacement therapy [commentary];Crawford;BMJ,2005

4. ASCO Breast Cancer Technology Assessment Working Group. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition;Chlebowski;J Clin Oncol,2002

5. Communicating the benefits of chronic preventive therapy;Hux;Med Decis Making,1995

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication use and climacteric syndrome: a cross-sectional population-based study;Menopause;2019-07-29

2. Considerations of Sex and Gender Differences in Preclinical and Clinical Trials;Sex and Gender Differences in Pharmacology;2012-09-05

3. Duration of vasomotor symptoms in middle-aged women;Menopause;2009-05

4. Revisiting the Duration of Vasomotor Symptoms of Menopause: A Meta-Analysis;Journal of General Internal Medicine;2008-06-03

5. Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis;Human Reproduction Update;2007-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3